| 【Company Research】Chinasoft (354 HK) – US is reviewing Huawei export license policy |
| 【Fixed Income Research】Yanlord: Resilient FY22 results and business model; maintain Buy |
| 【Company Research】WuXi Biologics (2269 HK) – Strong and sustainable non-COVID growth |
| 【Sector Research】Country Garden (2007 HK) – Mr. Yeung’s retirement not a surprise |
| 【Company Research】BeiGene (BGNE US) – Expect strong sales in 2023 driven by the US approval of zanubrutinib in CLL |
| 【Company Research】JNBY Design (3306 HK) – Eyes on the recovery and risk-reward |
| 【Sector Research】China Property Sector – Feb sales a strong beat; Raise 2023 forecast |
| 【Company Research】Yancoal Australia (3668 HK) – Net profit +3.5x YoY in 2022 but below expectations; Attractive yield of 20% |
| 【行业研究】中国互联网行业 – 关于《数字中国建设整体布局规划》的解读 |
| 【Company Research】China Technology – Semi field trip takeaways: darkness before dawn; fabless better positioned than SPE/materials |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
